Caitong International Asset Management Co., LTD Madrigal Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 429 shares of MDGL stock, worth $129,021. This represents 0.11% of its overall portfolio holdings.
Number of Shares
429
Previous 106
304.72%
Holding current value
$129,021
Previous $32.7 Million
334.44%
% of portfolio
0.11%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$663 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$631 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$608 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$600 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$594 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...